Rentabilitas dodolan miturut bathi resik Theriva Biologics (TOVX)

Tandha merek Theriva Biologics, Inc. (TOVX)

Theriva Biologics, Inc. (TOVX) maintains a strong reputation for developing adenoviruses to combat tumors. The net profit margin confirms this phase, with the indicator value standing at -3412.70. While the diversification of microbiome research mitigates risks, the current stage of development relies on the gradual depletion of existing reserves to fund costly scientific research.

TOVX: Rentabilitas resik perusahaan Theriva Corp 28.04.2023 - 20.11.2026

Rincian analitis perusahaan Theriva Biologics, Inc.

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:therivabio.com - TOVX
Barang unggulan Synthetic Biologics

The resilience of Theriva Biologics, Inc. (TOVX) is determined by its ability to maintain capital until the completion of clinical trials. The net profit margin trend reflects the efficiency of cost management in the absence of commercial revenues. This metric measures the share of residual income in revenue, revealing the business's ability to mitigate market shocks. For a biotech company with orphan statuses, this indicator serves as a marker of operational survival. Its stability directly impacts the fair valuation of future capitalization.

Analisis pesaing

NantKwest (IBRX) - Margin resik|Margin resik Immunocore PLC (IMCR)|Rentabilitas dodolan miturut bathi resik JANX|RCUS - Tingkat bathi miturut bathi resik|Rentabilitas dodolan miturut bathi resik ZYME (Zymeworks Corp)|Rentabilitas resik perusahaan TNGX|Margin dodolan resik IOVA (Iovance Biotherapeutics, Inc.)|Tingkat bathi resik IMTX|xencor.com - Margin dodolan resik|Margin resik Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Margin resik|Lyell Immunopharma - Tingkat bathi resik|IPHA (innate-pharma.com) - Margin dodolan resik|Margin dodolan resik pyxisoncology.com|Margin resik cgen.com (CGEN)|IOBT: Margin bathi resik|Sutro Biopharma Inc. - Rentabilitas dodolan miturut bathi resik|minktherapeutics.com (INKT) - Margin resik|HOWL: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Immix Biopharma IMMX|ALX Oncology (ALXO) - Margin resik|Margin resik Cue Biopharma, Inc. (CUE)|Margin resik PDS Biotechnology Corporation|Rentabilitas dodolan resik SONN (sonnetbio.com)|Margin dodolan resik MAIA|Margin dodolan perusahaan Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Rentabilitas dodolan miturut bathi resik|NXTC - Rentabilitas dodolan miturut bathi resik|LPTX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Rentabilitas dodolan miturut bathi resik|Margin resik Gritstone Bio (GRTS)|KA (Kineta Corp) - Margin dodolan resik|Rentabilitas dodolan resik NEXI (NexImmune Corp)|Margin dodolan resik TSBX|VCNX (Vaccinex, Inc.) - Tingkat bathi resik|Margin dodolan resik HARP (Harpoon Therapeutics, Inc.)